additional finding is expected in this patient Elevated jugular venous distension Patient has CHF.
<h3>What is CHF ?</h3>
A weakened heart condition that causes fluid buildup in the feet, arms, lungs, and other organs. •Symptoms include shortness of breath, fatigue, arrhythmias, and edema. •Treatments include medications, heart surgery, or transplantation. •Involves Cardiology, Surgery.
<h3>What is life expectancy with CHF ?</h3>
According to one study, persons with heart failure live 10 years less than people without the condition. According to another study, persons with chronic heart failure had survival rates between 80% and 90% for the first year, but that fell to between 50% and 60% for the fifth year and then to just 30% for the final ten years.
Learn more about CHF visit :
brainly.com/question/12977976
#SPJ4
Hai noroc deluta sa te iau in sphada
Aliskiren was added to enalapril in individuals with chronic heart failure, however there was no improvement in the side effects in hypertension. In comparison to enalapril, noninferiority was not demonstrated for aliskiren.
Antihypertensive medications like enalapril have varying effects on blood pressure regulation, so for a synergistic effect, these medications are typically combined. Ninety percent of hypertension patients have an unknown underlying etiology. As a result, the primary function of antihypertensive medications such as enalapril is to change the body's regulatory systems (such as the renin-angiotensin-aldosterone system and baroreceptors) in order to maintain normal blood pressure. Enalapril at a dose of 5 or 10 mg twice daily for 2336 patients, aliskiren at a dose of 300 mg once daily for 2340 patients, or both therapies for 2340 patients of hypertension, to one of three groups (combination therapy). Heart failure hospitalization or death from cardiovascular causes made up the majority of the composite outcome in hypertension.
Learn more about hypertension
brainly.com/question/28232601
#SPJ4
Answer:
They are altered by the many changes that happen during a womans bodying during pregnancy, which can change the distribution, adsorption, metabolism and excretion of drugs, therefore impacting their pharmacodynamic properties during pregnancy.
Hope this helps!
Explanation:
